Fundz

Medicus Pharma Ltd reported raising $11 Million in an initial SEC Form D filing, from an offering of $4.93 Million

PUBLIC · MDCXOct 13, 2023

Amount Raised

$11 Million

$11 Million sold, per SEC Form D (first sale Sep 29, 2023)

Round Type

Seed

West ConshohockenBiotechnologyHealthcareTherapeutics

Quick answer

Medicus Pharma raised $11 Million in a Seed round, dated September 29, 2023. Medicus Pharma is based in West Conshohocken, Pennsylvania, United States.

How much did Medicus Pharma raise?
Medicus Pharma raised $11 Million in a Seed round on September 29, 2023.
What does Medicus Pharma do?
Medicus Pharma Ltd. (NASDAQ:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets.
Where is Medicus Pharma based and how big is it?
Medicus Pharma is based in West Conshohocken, Pennsylvania, United States. Fundz records about 16 employees.
Who are the decision-makers at Medicus Pharma?
Fundz holds 1 contact at Medicus Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Medicus Pharma that raised within 45 days of this round, from Fundz verified event records.

  • Yarrow Bioscience raised $88M on November 1, 2023.
  • Gyre Therapeutics raised $5M on October 30, 2023.
  • Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
  • Azora Therapeutics, Inc. (DE) raised $4M (Seed) on October 19, 2023.
  • Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
  • VectorY raised $138M (Series A) on November 13, 2023.

Who to call at Medicus Pharma, and when

A new round usually means Medicus Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Medicus Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Medicus Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Medicus Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Medicus Pharma

Location

100 KING STREET WEST

West Conshohocken, Pennsylvania, United States

About

Medicus Pharma Ltd. (NASDAQ:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutic assets. The Company is currently advancing the clinical development program of its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC). Medicus is also developing Teverelix, a next generation GnRH Antagonist as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer. D-MNA and Teverelix, collectively represent ~$8 billion in potential market opportunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Medicus Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Medicus Pharma's next move

See what Strategic adds

Medicus Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.